Target Name: OR51A7
NCBI ID: G119687
Review Report on OR51A7 Target / Biomarker Content of Review Report on OR51A7 Target / Biomarker
OR51A7
Other Name(s): Olfactory receptor 51A7 | olfactory receptor OR11-27 | O51A7_HUMAN | OR11-27 | olfactory receptor family 51 subfamily A member 7 | Olfactory receptor family 51 subfamily A member 7 | Olfactory receptor OR11-27

OR51A7: A Potential Drug Target and Biomarker

OR51A7 is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. Its function is not well understood, but it is known to be involved in cell signaling and has been implicated in several diseases, including cancer and neurodegenerative disorders. As a result, OR51A7 has become a focus of interest in the pharmaceutical industry and may have potential as a drug target or biomarker.

The identification of potential drug targets is a crucial step in the development of new treatments for diseases. Drug targets are proteins that are thought to contribute to the pathogenesis of a disease and are targeted by drugs to disrupt their function. In the case of OR51A7, its involvement in cell signaling and potential involvement in several diseases has make it an attractive target for drug development.

OR51A7 is a protein that is expressed in the brain and has been implicated in the development and progression of several neurological disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. It is also involved in the regulation of pain perception and has been linked to the development of chronic pain. In addition, OR51A7 has been shown to be involved in the development of cancer, including pancreatic and colorectal cancer.

The potential benefits of targeting OR51A7 with drugs are significant. If successful, these drugs could provide new treatments for diseases that are currently difficult to treat or have a high impact on quality of life. In addition, targeting OR51A7 with drugs could also provide new insights into the underlying mechanisms of these diseases and could lead to the development of new targets for other therapies.

OR51A7 is also a potential biomarker for several diseases. The detection and quantification of OR51A7 expression in tissues could be used as a diagnostic tool for diseases, including cancer, neurodegenerative disorders, and chronic pain. In addition, the levels of OR51A7 in tissues could also be used as a target for drug development by monitoring the effectiveness of new treatments.

The development of new treatments for diseases is a complex and challenging process. The identification of potential drug targets and biomarkers is an important step in this process, but it is not the only one. The development of new treatments also requires a deep understanding of the underlying mechanisms of the disease, as well as the ability to design and conduct rigorous clinical trials to determine the safety and effectiveness of new treatments.

In conclusion, OR51A7 is a protein that has the potential to be a drug target and biomarker for several diseases. Its involvement in cell signaling and its implication in the development and progression of several neurological disorders makes it an attractive target for drug development. Further research is needed to fully understand its function and potential as a drug target and biomarker.

Protein Name: Olfactory Receptor Family 51 Subfamily A Member 7

Functions: Odorant receptor

The "OR51A7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR51A7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR51B2 | OR51B4 | OR51B5 | OR51B6 | OR51C1P | OR51D1 | OR51E1 | OR51E2 | OR51F1 | OR51F2 | OR51G1 | OR51G2 | OR51H1 | OR51I1 | OR51I2 | OR51J1 | OR51L1 | OR51M1 | OR51Q1 | OR51S1 | OR51T1 | OR51V1 | OR52A1 | OR52A4P | OR52A5 | OR52B2 | OR52B4 | OR52B6 | OR52D1 | OR52E1 | OR52E2 | OR52E4 | OR52E5 | OR52E6 | OR52E8 | OR52H1 | OR52I1 | OR52I2 | OR52J3 | OR52K1 | OR52K2 | OR52K3P | OR52L1 | OR52M1 | OR52N1 | OR52N4 | OR52N5 | OR52R1 | OR52W1 | OR52Z1P | OR56A1 | OR56A3 | OR56A4 | OR56A5 | OR56B1 | OR56B4 | OR5A1 | OR5A2 | OR5AC1 | OR5AC2 | OR5AK2 | OR5AK4P | OR5AN1 | OR5AP2 | OR5AR1 | OR5AS1 | OR5AU1 | OR5B12 | OR5B17 | OR5B2 | OR5B21 | OR5B3 | OR5BA1P | OR5C1 | OR5D13 | OR5D14 | OR5D16 | OR5D17P | OR5D18 | OR5E1P | OR5F1 | OR5H1 | OR5H14 | OR5H15 | OR5H2 | OR5H4P | OR5H6 | OR5I1 | OR5K1 | OR5K2 | OR5K3 | OR5K4 | OR5L1 | OR5L2 | OR5M1 | OR5M10 | OR5M11 | OR5M3 | OR5M4P | OR5M8